{
    "Trade/Device Name(s)": [
        "APTIMA Combo 2 Assay"
    ],
    "Submitter Information": "Hologic | Gen-Probe Incorporated",
    "510(k) Number": "K132251",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111409"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MKZ",
        "LSL",
        "NSU"
    ],
    "Summary Letter Date": "July 22, 2013",
    "Summary Letter Received Date": "July 23, 2013",
    "Submission Date": "July 18, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.3120",
        "21 CFR 866.3390"
    ],
    "Regulation Name(s)": [
        "Chlamydia serological reagents",
        "Neisseria spp. direct serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis",
        "Neisseria gonorrhoeae"
    ],
    "Specimen Type(s)": [
        "Clinician-collected endocervical swab",
        "Clinician-collected vaginal swab",
        "Male urethral swab",
        "Clinician-collected gynecological specimen in PreservCyt Solution",
        "Patient-collected vaginal swab",
        "Male urine"
    ],
    "Specimen Container(s)": [
        "APTIMA specimen transport tube",
        "PreservCyt Solution container"
    ],
    "Instrument(s)/Platform(s)": [
        "PANTHER System"
    ],
    "Method(s)/Technology(ies)": [
        "Target capture",
        "Transcription-mediated amplification (TMA)",
        "Dual kinetic assay (DKA)",
        "Chemiluminescent DNA probe"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Hybridization protection assay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for APTIMA Combo 2 Assay for qualitative detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae rRNA on PANTHER System, including male urine specimens",
    "Indications for Use Summary": "Qualitative detection and differentiation of ribosomal RNA from Chlamydia trachomatis and/or Neisseria gonorrhoeae to aid diagnosis of chlamydial and/or gonococcal urogenital disease in specified swab, gynecological, and male urine specimens using the PANTHER System",
    "fda_folder": "Microbiology"
}